Viewing Study NCT06998095


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-01-01 @ 2:08 PM
Study NCT ID: NCT06998095
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module